Ibudilast (AV-411)

@article{Ledeboer2007Ibudilast,
  title={Ibudilast (AV-411)},
  author={Annemarie Ledeboer and Mark R Hutchinson and Linda R Watkins and Kirk W Johnson},
  journal={Expert Opinion on Investigational Drugs},
  year={2007},
  volume={16},
  pages={935 - 950}
}
The treatment of neuropathic pain is a major unresolved medical challenge. Present pharmacotherapies only have modest efficacy and numerous side effects. The use of opioid analgesics is additionally coupled with dependence and withdrawal syndromes. Ibudilast (AV-411) is a non-selective phosphodiesterase inhibitor that is also known to suppress glial cell activation. It has been used clinically for other indications with a good safety profile. As glial cell activation is considered to crucially… Expand
Anticytokine therapy in neuropathic pain management
Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease
Neuroimmune interactions and pain: focus on glial-modulating targets.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 147 REFERENCES
The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain.
Gabapentin in the treatment of neuropathic pain
Emerging therapies for neuropathic pain
Emerging trends in the pharmacotherapy of chronic pain
Glia: novel counter-regulators of opioid analgesia
Neuropathic pain: symptoms, models, and mechanisms
Ibudilast: a non-selective PDE inhibitor with multiple actions on blood cells and the vascular wall.
Neuroimmune Activation and Neuroinflammation in Chronic Pain and Opioid Tolerance/Hyperalgesia
  • J. Deleo, F. Tanga, V. Tawfik
  • Medicine
  • The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry
  • 2004
...
1
2
3
4
5
...